References
- Macri J. N., Kasturi R. V., Krantz D. A., Cook E. J., Moore N. J., Young J. A., Romero K., Larsen J. W. Jr. Maternal serum Down syndrome screening: Free b-protein is a more effective marker than human chorionic gonadotrophin. Amer J Obstet Gynecol 1990; 163: 1248–1253
- Nørgaard-Pedersen B., Olesen S. Larsen, Arends J., Svenstrup B., Tabor A. Maternal serum markers in screening for Down syndrome. Clinical Genetics 1990; 37: 35–43
- Penttilä I.M., Puhakainen E., Ryynänen M. Selecting a sensitive immunoradiometric method of maternal serum alphafetoprotein for prenatal screening of abnormalities in the fetus. Upsala J Med Sci. 1990; 95: 287–290
- Puhakainen E., Ryynänen M. The use of a sensitive alpha-fetoprotein method and low maternal serum value in the screening of trisomies during the second trimester of pregnancy. Biochimica Clinica 1989; 13(Suppl. 1/8)329
- Ryynänen M. “Screening of fetal malformations with the measurement of alpha-fetoprotein of maternal serum in Eastern Finland”. Publications of the University of Kuopio, Medicine, Finland 1981; 1–81, Original reports 4/
- Seppälä M., Aula P., Rapola J., Karjalainen O., Huttunen N-P., Ruoslathi E. Congenital nephrotic syndrome: prenatal diagnosis and genetic counselling by estimation of amniotic-fluid and maternal serum alpha-fetoprotein. Lancet 1976; 2: 123–125
- Spencer K. Evaluation of an assay of the free b-subunit of the choriogonadotropin and its potential value in screening for Down's syndrome. Clin Chem 1991; 37: 809–814
- Wald N. J., Cuckle H. S., Densem J. W., Nanchahal K., Royston P., Chard T., Haddow J. E., Knight G. J., Palomaki G. E., Canick J. A. Maternal serum screening for Down's syndrome in early pregnancy. Brit Med j 1988; 297: 883–887